BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16251320)

  • 41. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
    Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
    Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli.
    Mnif B; Vimont S; Boyd A; Bourit E; Picard B; Branger C; Denamur E; Arlet G
    J Antimicrob Chemother; 2010 Aug; 65(8):1599-603. PubMed ID: 20507859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and characterisation of CTX-M and CMY-2 beta-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China.
    Liu JH; Wei SY; Ma JY; Zeng ZL; Lü DH; Yang GX; Chen ZL
    Int J Antimicrob Agents; 2007 May; 29(5):576-81. PubMed ID: 17314033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CTX-M type beta-lactamases among fecal Escherichia coli and Klebsiella pneumoniae isolates in non-hospitalized children and adults.
    Ho PL; Wong RC; Chow KH; Yip K; Wong SS; Que TL
    J Microbiol Immunol Infect; 2008 Oct; 41(5):428-32. PubMed ID: 19122926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt.
    Mohamed Al-Agamy MH; El-Din Ashour MS; Wiegand I
    Int J Antimicrob Agents; 2006 Jun; 27(6):545-8. PubMed ID: 16713187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
    Onnberg A; Mölling P; Zimmermann J; Söderquist B
    APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK.
    Doumith M; Dhanji H; Ellington MJ; Hawkey P; Woodford N
    J Antimicrob Chemother; 2012 Apr; 67(4):878-85. PubMed ID: 22210753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic characterisation of extended-spectrum β-lactamases in Escherichia coli isolated from retail chicken products including CTX-M-9 containing isolates: a food safety risk factor.
    Silva N; Costa L; Gonçalves A; Sousa M; Radhouani H; Brito F; Igrejas G; Poeta P
    Br Poult Sci; 2012; 53(6):747-55. PubMed ID: 23398418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and molecular characterization of CTX-M β-lactamase-producing Escherichia coli isolated from healthy swine and cattle.
    Tamang MD; Nam HM; Kim SR; Chae MH; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2013 Jan; 10(1):13-20. PubMed ID: 23210923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases.
    Marcadé G; Deschamps C; Boyd A; Gautier V; Picard B; Branger C; Denamur E; Arlet G
    J Antimicrob Chemother; 2009 Jan; 63(1):67-71. PubMed ID: 18931389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital.
    Yano H; Uemura M; Endo S; Kanamori H; Inomata S; Kakuta R; Ichimura S; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Gu Y; Yamada M; Tokuda K; Kunishima H; Kitagawa M; Hirakata Y; Kaku M
    PLoS One; 2013; 8(5):e64359. PubMed ID: 23691204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.